Condition category
Nutritional, Metabolic, Endocrine
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information



Primary contact

Dr Simon Griffin


Contact details

MRC Epidemiology Unit
Institute of Metabolic Science
Box 285
Addenbrooke's Hospital
Hills Road
United Kingdom
+44 (0)1223 330315

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Trial of efficacy of a family-based programme to increase physical activity among individuals at high risk of diabetes



Study hypothesis

1. Behaviour change: to estimate the extent to which an innovative approach to increasing physical activity can achieve clinically important changes in a high risk group
2. Disease impact: to model the potential for this behaviour change to reduce the incidence of obesity and diabetes in later life
3. Dose finding: to estimate the effect of delivery of the intervention at two levels of intensity on acceptability, efficacy and costs

Please note that as of 18/03/2009 this record was updated; all updates can be found under the relevant field with the above updated date. Please also note that at this time, details of the follow-up study 'ProActive: follow-up study' were added to this record. All details of this follow-up study can be found in the relevant section under the sub-heading 'ProActive: follow-up study'. The ProActive: follow-up study has the following trial dates:
Overall trial start date: 01/04/2009
Overall trial end date: 01/10/2011

ProActive: follow-up study -
We aim to follow-up ProActive trial participants and to quantify changes in objectively measured physical activity and its clinical and psychological correlates over time. Specific objectives include:

1. Assessment of changes in physical activity and its consequences:
1.1. To determine the efficacy of the ProActive intervention programme on objectively measured physical activity and its clinical and psychological correlates five years post-randomisation
1.2. To examine to what extent observed increases in objectively measured physical activity at one year in the ProActive cohort were sustained
1.3. To conduct a cohort analysis to examine whether feasible changes in objectively measured physical activity are associated with clinically important changes in metabolic risk factors

2. Assessment of the determinants of physical activity and self-rated health:
2.1. To characterise individuals who maintained, increased and decreased their levels of physical activity by quantifying the association between determinants and change in physical activity over time. We will examine individual and environmental determinants of physical activity:
2.1.1. Individual determinants: biological, behavioural, demographic, psychological
2.1.2. Environmental determinants: both objective and perceived environmental data
2.2. To examine which psychological variables (e.g. intention, perceived behavioural control, satisfaction) predict long-term change in physical activity in the whole cohort and whether predictors differ across the three trial arms
2.3. To similarly identify predictors and outcomes of self-rated health in a cohort of healthy adults in order to better understand the mechanisms by which self-rated health is created and how it influences outcomes

3. Adding meaning to the trial and cohort study findings:
3.1. To elicit participants' perceptions of self-rated health and explore the reasons for the effect of the intervention on self-rated health
3.2. To analyse individuals' reflections on participating in the ProActive study, their understandings of the specific intervention they received, and their personal reports of the impact these aspects had on them
3.3. To elicit and analyse personal accounts of activity change, and explore the extent to which this is interpreted as a result of the original intervention, of some other aspect of trial involvement, or because of other influences related to their social or physical environment
3.4. To understand better the barriers and facilitators of long term changes in physical activity, and their relationship with self-rated health and perceptions of disease risk through exploring participants' own perceptions and meanings

Ethics approval

1. Eastern MREC, 31/10/2002, ref: 02/5/53
2. ProActive: follow-up study - Cambridgeshire 2 REC, 23/01/2009, ref: 09/H0308/3

Study design

Randomised controlled trial and long-term follow-up

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet




Three levels of facilitating physical activity:
1. Face to face of a programme to support motivation, action
2. Telephone delivery and maintenance
3. Comparison group (brief advice by leaflet)

Interventions 1 and 2 are delivered by a facilitator trained in evidence-based methods from psychology.

Added 18/03/2009:
The intervention lasted 12 months; 5 months of intensive intervention followed by 7 months of follow-up.

Co-sponsor as of March 2009 (along with University of Cambridge - see sponsor section below):
MRC Epidemiology Unit (UK)
Institute of Metabolic Science, Box 285
Addenbrooke's Hospital
Hills Road
Cambridge CB2 0QQ
United Kingdom

Initial sponsor at time of registration until March 2009:
CamStrad (Cambridgeshire Support Team - Research & Development) (UK)

Intervention type



Not Applicable

Drug names

Primary outcome measures

An objective measure of physical activity (PAL), daytime energy expenditure and its ration to basal metabolic rate. Psychological and physiological correlates of this behaviour and costs to the NHS will also be measured.

ProActive: follow-up study -
Physical activity measured as the daytime physical activity ratio (dayPAR). This is the ratio of daytime energy expenditure to resting energy expenditure measured using heart rate monitoring with individual calibration for the heart rate-energy expenditure relationship. The method has been extensively validated:
1. Oxygen uptake (ml O2/kg/body weight) will be measured by indirect calorimetry during a submaximal graded treadmill exercise test
2. Maximal cardiorespiratory fitness (VO2max) will be estimated using predicted maximal heart rate (i.e. 220 minus age)
3. Activity energy expenditure (AEE) will be individually calculated from heart rate monitoring as the amount of energy expended above that during a standardised reference activity (i.e. treadmill walking at 3.2 km.h-1)
4. Time (% of monitored time per day) spent above 1.75 resting heart rate will be individually calculated as an indicator of moderate intensity PA

Physical activity will also be measured by the EPAQ2 questionnaire covering work, recreation and domestic activity over the previous month and year.

Secondary outcome measures

Added 18/03/2009:
Measured at baseline and at 1 year:
1. Maximal cardiorespiratory fitness (VO2max)
2. Self-reported physical activity
3. Weight
4. Height
5. Body fat percentage
6. Blood pressure
7. Glycosylated haemoglobin
8. Fasting plasma glucose, lipids and insulin
9. 36-item short form health survey (SF-36) (wellbeing)
10. Worry about diabetes and perceived risk of diabetes
11. Psychological outcomes including beliefs about increasing physical activity (e.g. attitude, subjective norm, intention, perceived behavioural control), based on the Theory of Planned Behaviour

All self-reported questionnaires (except the SF-36) were also collected at 6 months. At 6 months and 1 year participants were asked about the acceptability of the programme and it's delivery.

ProActive: follow-up study -
1. Physiological correlates of activity:
1.1. Weight measured on standard scales calibrated at three monthly intervals
1.2. Body fat percentage measured by bio-electrical impedance (Bodystat, Isle of Man, UK)
1.3. Systolic/diastolic blood pressure, measured using an automatic sphygmomanometer (Accutorr, UK)
2. An electrocardiogram (ECG) will be performed
3. Biochemical correlates, including fasting plasma glucose, insulin, glycosylated haemoglobin, and lipids measured in one laboratory with established quality assurance systems
4. Psychological outcomes, including beliefs about increasing physical activity over the coming 12 months (e.g. attitude, subjective norm, intention, perceived behavioural control), based on the Theory of Planned Behaviour
5. Self-report measures of well-being and quality of life, including subjective health and energy (SF-36)

A follow-up qualitative component - a two-stage interview procedure - will also be performed at follow-up

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

Offspring of patients with Type 2 diabetes reporting a sedentary lifestyle.

ProActive: follow-up study -
Existing participants we are able to contact who are willing and able to attend for follow-up measures.

Participant type


Age group




Target number of participants

365 (ProActive: follow-up study - 353)

Participant exclusion criteria

1. Age greater than 30 years, less than 50 years
2. Known diabetes
3. Physical or psychiatric illness limiting programme involvement

ProActive: follow-up study -
Participants who are unable to be contacted, or unable or unwilling to attend for follow-up measures.

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Addenbrooke's Hospital
United Kingdom

Sponsor information


University of Cambridge (UK)

Sponsor details

Research Services Division
16 Mill Lane
United Kingdom

Sponsor type




Funder type

Research council

Funder name

Medical Research Council (MRC) (UK) (ref: G0000753)

Alternative name(s)


Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit


United Kingdom

Funder name

National Institute for Health Research (NIHR) (UK) - School for Primary Care Research

Alternative name(s)

Funding Body Type

Funding Body Subtype


Funder name

Medical Research Council (MRC) Epidemiology Unit (UK) Programme funding

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1. 2004 protocol in:
2. 2008 results in:
3. 2009 results in:
4. 2010 results in:
5. 2011 results in:
6. 2014 results in:
7. 2015 results in:

Publication citations

  1. Protocol

    Williams K, Prevost AT, Griffin S, Hardeman W, Hollingworth W, Spiegelhalter D, Sutton S, Ekelund U, Wareham N, Kinmonth AL, The ProActive trial protocol - a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766]., BMC Public Health, 2004, 4, 48, doi: 10.1186/1471-2458-4-48.

  2. Results

    Kinmonth AL, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T, Williams KM, Ekelund U, Spiegelhalter D, Griffin SJ, Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial., Lancet, 2008, 371, 9606, 41-48, doi: 10.1016/S0140-6736(08)60070-7.

  3. Results

    Simmons RK, van Sluijs EM, Hardeman W, Sutton S, Griffin SJ, , Who will increase their physical activity? Predictors of change in objectively measured physical activity over 12 months in the ProActive cohort., BMC Public Health, 2010, 10, 226, doi: 10.1186/1471-2458-10-226.

  4. Results

    Hardeman W, Michie S, Kinmonth AL, Sutton S, , Do increases in physical activity encourage positive beliefs about further change in the ProActive cohort?, Psychol Health, 2011, 26, 7, 899-914, doi: 10.1080/08870446.2010.512662.

  5. Results

    Wijndaele K, Orrow G, Ekelund U, Sharp SJ, Brage S, Griffin SJ, Simmons RK, Increasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study., Diabetologia, 2014, 57, 2, 305-312, doi: 10.1007/s00125-013-3102-y.

  6. Hardeman W, Kinmonth AL, Michie S, Sutton S, , Impact of a physical activity intervention program on cognitive predictors of behaviour among adults at risk of Type 2 diabetes (ProActive randomised controlled trial)., Int J Behav Nutr Phys Act, 2009, 6, 16, doi: 10.1186/1479-5868-6-16.

  7. Results

    Golubic R, Wijndaele K, Sharp SJ, Simmons RK, Griffin SJ, Wareham NJ, Ekelund U, Brage S; ProActive Study Group, Physical activity, sedentary time and gain in overall and central body fat: 7-year follow-up of the ProActive trial cohort, Int J Obes (Lond), 2015 , 39, 1, 142-148, doi: 10.1038/ijo.2014.66.

Additional files

Editorial Notes